JIA HE IMP AND EXP TRADING CO., LIMITED

Executive Summary

JIA HE IMP AND EXP TRADING CO., LIMITED is a newly formed dormant company with no trading history or financial activity. The lack of operational data and minimal balance sheet restricts any meaningful credit assessment. Credit facilities should be declined until trading performance and financial strength are evident in future filings.

JIA HE IMP AND EXP TRADING CO., LIMITED - Analysis Report

Company Number: 15077085

Analysis Date: 2025-07-20 14:28 UTC

1. Credit Opinion: DECLINE
   JIA HE IMP AND EXP TRADING CO., LIMITED is a newly incorporated dormant company with no trading activity or financial history beyond the initial share capital. The company’s net assets and shareholders’ funds stand at a nominal £1,000 with no revenue or profit data available. There is no evidence of operational cash flow or trading ability to service any credit facilities. Given the absence of any trading record or financial performance, extending credit at this stage presents a high risk.

2. Financial Strength:
   The balance sheet is minimal, showing only the initial £1,000 share capital and matching net assets. No liabilities or current assets exist. This indicates no tangible financial strength or buffer to absorb operational risks or economic downturns. The company being dormant means it has no assets generating income or cash flows.

3. Cash Flow Assessment:
   There is no cash flow information since the company is dormant and has not commenced trading. Working capital position is effectively neutral at the moment. Without trading activity, there is no liquidity to support debt servicing or working capital needs.

4. Monitoring Points:

• Monitor for the first set of trading accounts to assess revenue, profitability, and cash flow generation.
• Watch for any increase in assets or liabilities indicating operational activity or credit exposure.
• Review director’s plans and business model clarity once trading commences.
• Monitor compliance with filing deadlines to ensure ongoing regulatory adherence.